EUSA Pharma

EUSA Pharma, founded in 2006, operates in the biotechnology, healthcare, and pharmaceutical industries with its headquarters in the United Kingdom. The company, a part of Recordati Rare Diseases, focuses on transforming the lives of people affected by cancer or rare diseases globally. With a commitment to addressing gaps in adult and pediatric care, EUSA Pharma collaborates with a dedicated staff of more than 4,300 within the Recordati group. The most recent investment, a Venture Round at May 24, 2009, involved SV Health Investors and Advent Venture Partners. The company's dedication to helping individuals with limited treatment options underscores its mission. For more information, visitors can refer to the press release on the official website of Recordati Rare Diseases. EUSA Pharma's commitment to innovation and patient-centric approach makes it an interesting prospect for venture capital firms seeking opportunities in the pharmaceutical and healthcare sectors.